Next Generation COVID Vaccines Incoming
September 5, 2022
Regulators in the United States, United Kingdom and European Union have approved Omicron-specific vaccines in recent weeks, but an application to authorise variant vaccines in New Zealand still isn’t expected for months.
The EU and UK have both approved vaccines targeting the original BA.1 Omicron variant, while the American Food and Drug Administration green lit a Pfizer jab aimed at the BA.4 and BA.5 subvariants.
While BA.5 is the dominant subvariant globally and in New Zealand, both shots are expected to provide even better protection than the original vaccines.
Prepare for more authoritarian measures.